Licensing deals

Photo of a final puzzle piece about to fit into a puzzle

Biotech

NextCure advances ADC pivot with $745M deal for phase 1 drug

NextCure has ramped up its ADC pivot, penning a $745 million deal for the ex-China rights to Simcere Zaiming’s phase 1-stage tumor asset.

James Waldron Jun 16, 2025 9:52am

AstraZeneca

AstraZeneca pens $5.3B pact with CSPC to develop oral drugs

Jun 13, 2025 5:56am

Anatomical model of human arm and torso showing muscle

Eli Lilly inks $650M Juvena pact to find muscle-boosting drugs

Jun 11, 2025 7:30am

finance numbers tape money

Novo Nordisk inks $812M Deep Apple deal to pursue obesity target

Jun 11, 2025 7:00am

Three blocks displaying from left to right a person a handshake and another person

BMS expands radiopharma pipeline

Jun 11, 2025 4:31am

pipelines in the sun

Seyltx gains option to boost cough pipeline with 8 NeurOp drugs

Jun 5, 2025 10:40am